Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API’s, Intermediates and Nutraceutical ingredients
Financial Results:
Divis Laboratories Ltd reported Revenues for Q3FY25 of ₹2,319.00 Crores up from ₹1,855.00 Crore year on year, a rise of 25.01%.
Total Expenses for Q3FY25 of ₹1,675.00 Crores up from ₹1,461.00 Crores year on year, a rise of 14.65%.
Consolidated Net Profit of ₹589.00 Crores up 64.53% from ₹358.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹22.19, up 64.49% from ₹13.49 in the same quarter of the previous year.